Publisher
Springer Science and Business Media LLC
Subject
Critical Care and Intensive Care Medicine
Reference5 articles.
1. Bassetti M, De Waele JJ, Eggimann P, Garnacho-Montero J, Kahlmeter G, Menichetti F et al (2015) Preventive and therapeutic strategies in critically ill patients with highly resistant bacteria. Intensive Care Med 41:776–795
2. Wertheim H, Van Nguyen K, Hara GL, Gelband H, Laxminarayan R, Mouton J et al (2013) Global survey of polymyxin use: a call for international guidelines. J Glob Antimicrob Resist 1:131–134
3. Garonzik SM, Li J, Thamlikitkul V, Paterson DL, Shoham S, Jacob J, Silveira FP et al (2011) Population pharmacokinetics of colistin methanesulfonate and formed colistin in critically ill patients from a multicenter study provide dosing suggestions for various categories of patients. Antimicrob Agents Chemother 55:3284–3294
4. Polymyxin Article-31 referral—annex II.
http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/referrals/Polymyxin-containing_medicines/human_referral_000383.jsp&mid=WC0b01ac05805c516f
. Assessed Jan 2017
5. Nation RL, Garonzik SM, Li J, Thamlikitkul V, Giamarellos-Bourboulis EJ, Paterson DL et al (2016) Updated United States and European dose recommendations for intravenous colistin: how do they perform? Clin Infect Dis 62:552–558
Cited by
8 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献